Advances in™ Congenital Adrenal Hyperplasia: Investigating the Impact of Emerging Agents

Activity Overview
This online educational activity is designed to provide expert interpretation of new and emerging data on the treatment of congenital adrenal hyperplasia (CAH), with a forward-looking perspective on how new and novel agents might impact clinical practice. The essentials of disease classification and clinical trial data, current and emerging treatment strategies, and management of CAH from infancy to adulthood will be presented in a multimedia format, including a series of video interviews with an expert thought leader integrated into text-based elements.

Target Audience
This educational activity is directed toward endocrinologists, pediatricians, primary care clinicians, nurse practitioners, physician assistants, registered nurses, and other health care practitioners involved in the management of patients with CAH.

Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
• Discuss the burden of CAH on patients
• Apply guideline recommendations for the management of patients with CAH
• Evaluate clinical trial data for emerging agents for the treatment of CAH